Mennillo, Elvira http://orcid.org/0000-0002-3210-1004
Kim, Yang Joon
Lee, Gyehyun
Rusu, Iulia
Patel, Ravi K. http://orcid.org/0000-0001-5203-899X
Dorman, Leah C.
Flynn, Emily
Li, Stephanie
Bain, Jared L.
Andersen, Christopher
Rao, Arjun
Tamaki, Stanley
Tsui, Jessica
Shen, Alan
Lotstein, Madison L.
Rahim, Maha
Naser, Mohammad http://orcid.org/0000-0002-9025-2759
Bernard-Vazquez, Faviola
Eckalbar, Walter
Cho, Soo-jin http://orcid.org/0000-0001-6324-6858
Beck, Kendall
El-Nachef, Najwa
Lewin, Sara
Selvig, Daniel R.
Terdiman, Jonathan P.
Mahadevan, Uma
Oh, David Y.
Fragiadakis, Gabriela K. http://orcid.org/0000-0001-9703-2591
Pisco, Angela http://orcid.org/0000-0003-0142-2355
Combes, Alexis J. http://orcid.org/0000-0002-9110-6542
Kattah, Michael G. http://orcid.org/0000-0002-6067-6585
Funding for this research was provided by:
Crohn's and Colitis Foundation
Article History
Received: 21 January 2023
Accepted: 30 January 2024
First Online: 19 February 2024
Competing interests
: S. Lewin has received research support from Takeda. N. El-Nachef is a consultant for Ferring, Federation Bio Grant, and receives funding from Finch Therapeutics, Seres, Freenome, and Assembly Biosciences. U. Mahadevan serves as a consultant for Abbvie, BMS, Boeringher Ingelheim, Gilead, Janssen, Lilly, Pfizer, Prometheus biosciences, Protagonist, Rani Therapeutics, Surrozen, and Takeda. D. Oh has received research support from Merck, PACT Pharma, the Parker Institute for Cancer Immunotherapy, Poseida Therapeutics, TCR2 Therapeutics, Roche/Genentech, and Nutcracker Therapeutics, and travel/accommodations from Roche/Genentech. The Combes lab has received research support from Eli Lilly and Genentech and A. Combes consults for Foundery Innovations. The Kattah lab receives research support from Eli Lilly. M. Kattah has consulted for Sonoma Biotherapeutics and Morphic Therapeutic. The remaining authors declare no competing interests.